Skip to main content
SpringerLink
Log in

ALCAR Exerts Neuroprotective and Pro-Neurogenic Effects by Inhibition of Glial Activation and Oxidative Stress via Activation of the Wnt/β-Catenin Signaling in Parkinsonian Rats

  • Published:
Molecular Neurobiology Aims and scope Submit manuscript

Abstract

Oxidative stress and neuroinflammation are known causative factors in progressive degeneration of dopaminergic (DAergic) neurons in Parkinson’s disease (PD). Neural stem cells (NSCs) contribute in maintaining brain plasticity; therefore, survival of NSCs and neuroblasts during neurodegenerative process becomes important in replenishing the pool of mature neuronal population. Acetyl-l-carnitine (ALCAR), present in almost all body cells, increases endogenous antioxidants and regulates bioenergetics. Currently, no information is available about the putative mechanism and neuroprotective effects of ALCAR in 6-hydroxydopamine (6-OHDA)-induced rat model of PD-like phenotypes. Herein, we investigated the effect of ALCAR on death/survival of DAergic neurons, neuroblasts and NSCs and associates mechanism of neuroprotection in 6-OHDA-induced rat model of PD-like phenotypes. ALCAR (100 mg/kg/day, intraperitoneal (i.p.)) treatment started 3 days prior to 6-OHDA lesioning and continued for another 14 day post-lesioning. We found that ALCAR pretreatment in 6-OHDA-lesioned rats increased expression of neurogenic and the Wnt pathway genes in the striatum and substantia nigra pars compacta (SNpc) region. It suppressed the glial cell activation, improved antioxidant status, increased NSC/neuroblast population and rescued the DAergic neurons in nigrostriatal pathway. ALCAR pretreatment in 6-OHDA-lesioned rats decreased GSK-3β activation and increased nuclear translocation of β-catenin. Functional deficits were restored following ALCAR pretreatment in 6-OHDA-lesioned rats as demonstrated by improved motor coordination and rotational behaviour, confirming protection of DAergic innervations in lesioned striatum. These results indicate that ALCAR exerts neuroprotective effects through the activation of Wnt/β-catenin pathway, suggesting its therapeutic use to treat neurodegenerative diseases by enhancing regenerative capacity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

References

  1. Walsh S, Finn DP, Dowd E (2011) Time-course of nigrostriatal neurodegeneration and neuroinflammation in the 6-hydroxydopamine-induced axonal and terminal lesion models of Parkinson’s disease in the rat. Neuroscience 175:251–261

    Article  CAS  PubMed  Google Scholar 

  2. Block ML, Zecca L, Hong JS (2007) Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci 8:57–69

    Article  CAS  PubMed  Google Scholar 

  3. Sawada H, Hishida R, Hirata Y, Ono K, Suzuki H, Muramatsu S et al (2007) Activated microglia affect the nigro-striatal dopamine neurons differently in neonatal and aged mice treated with 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine. J Neurosci Res 85:1752–1761

    Article  CAS  PubMed  Google Scholar 

  4. Hirsch EC, Hunot S (2009) Neuroinflammation in Parkinson’s disease: a target for neuroprotection? Lancet Neurol 8:382–397

    Article  CAS  PubMed  Google Scholar 

  5. Hu X, Zhang D, Pang H, Caudle WM, Li Y, Gao H et al (2008) Macrophage antigen complex-1 mediates reactive microgliosis and progressive dopaminergic neurodegeneration in the MPTP model of Parkinson’s disease. J Immunol 181:7194–7204

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Morale MC et al (2006) Estrogen, neuroinflammation and neuroprotection in Parkinson’s disease: glia dictates resistance versus vulnerability to neurodegeneration. Neuroscience 138:869–878

    Article  CAS  PubMed  Google Scholar 

  7. Yang F, Liu Y, Tu J, Wan J, Zhang J, Wu B et al (2014) Activated astrocytes enhance the dopaminergic differentiation of stem cells and promote brain repair through bFGF. Nat Commun 5:5627

    Article  PubMed  PubMed Central  Google Scholar 

  8. Monje ML, Toda H, Palmer TD (2003) Inflammatory blockade restores adult hippocampal neurogenesis. Science 302:1760–1765

    Article  CAS  PubMed  Google Scholar 

  9. Worlitzer MM, Bunk EC, Hemmer K, Schwamborn JC (2012) Anti-inflammatory treatment induced regenerative oligodendrogenesis in parkinsonian mice. Stem Cell Res Ther 3:33

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Zhang L, Yang X, Yang S, Zhang J (2011) The Wnt/beta-catenin signaling pathway in the adult neurogenesis. Eur J Neurosci 33:1–8

    Article  PubMed  Google Scholar 

  11. L’Episcopo F, Serapide MF, Tirolo C, Testa N, Caniglia S, Morale MC et al (2011) A Wnt1 regulated Frizzled-1/beta-Catenin signaling pathway as a candidate regulatory circuit controlling mesencephalic dopaminergic neuron-astrocyte crosstalk: therapeutical relevance for neuron survival and neuroprotection. Mol Neurodegener 6:49

    Article  PubMed  PubMed Central  Google Scholar 

  12. Gordon MD, Nusse R (2006) Wnt signaling: multiple pathways, multiple receptors, and multiple transcription factors. J Biol Chem 281:22429–22433

    Article  CAS  PubMed  Google Scholar 

  13. L’Episcopo F, Tirolo C, Testa N, Caniglia S, Morale MC, Deleidi M et al (2012) Plasticity of subventricular zone neuroprogenitors in MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) mouse model of Parkinson’s disease involves cross talk between inflammatory and Wnt/beta-catenin signaling pathways: functional consequences for neuroprotection and repair. J Neurosci 32:2062–2085

    Article  PubMed  PubMed Central  Google Scholar 

  14. Dun Y, Li G, Yang Y, Xiong Z, Feng M, Wang M et al (2012) Inhibition of the canonical Wnt pathway by Dickkopf-1 contributes to the neurodegeneration in 6-OHDA-lesioned rats. Neurosci Lett 525:83–88

    Article  CAS  PubMed  Google Scholar 

  15. Savitha S, Tamilselvan J, Anusuyadevi M, Panneerselvam C (2005) Oxidative stress on mitochondrial antioxidant defense system in the aging process: role of DL-alpha-lipoic acid and L-carnitine. Clin Chim Acta 355:173–180

    Article  CAS  PubMed  Google Scholar 

  16. Harsing LG Jr, Sershen H, Toth E, Hashim A, Ramacci MT, Lajtha A (1992) Acetyl-L-carnitine releases dopamine in rat corpus striatum: an in vivo microdialysis study. Eur J Pharmacol 218:117–121

  17. Tolu P, Masi F, Leggio B, Scheggi S, Tagliamonte A, De Montis MG et al (2002) Effects of long-term acetyl-L-carnitine administration in rats: I. increased dopamine output in mesocorticolimbic areas and protection toward acute stress exposure. Neuropsychopharmacology 27:410–420

    Article  CAS  PubMed  Google Scholar 

  18. Zaitone SA, Abo-Elmatty DM, Shaalan AA (2011) Acetyl-L-carnitine and alpha-lipoic acid affect rotenone-induced damage in nigral dopaminergic neurons of rat brain, implication for Parkinson’s disease therapy. Pharmacol Biochem Behav 100:347–360

    Article  PubMed  Google Scholar 

  19. Hota KB, Hota SK, Chaurasia OP, Singh SB (2012) Acetyl-L-carnitine-mediated neuroprotection during hypoxia is attributed to ERK1/2-Nrf2-regulated mitochondrial biosynthesis. Hippocampus 22:723–736

    Article  CAS  PubMed  Google Scholar 

  20. Montgomery SA, Thal LJ, Amrein R (2003) Meta-analysis of double blind randomized controlled clinical trials of acetyl-L-carnitine versus placebo in the treatment of mild cognitive impairment and mild Alzheimer’s disease. Int Clin Psychopharmacol 18:61–71

    Article  PubMed  Google Scholar 

  21. Shukla S, Chaturvedi RK, Seth K, Roy NS, Agrawal AK (2009) Enhanced survival and function of neural stem cells-derived dopaminergic neurons under influence of olfactory ensheathing cells in parkinsonian rats. J Neurochem 109:436–451

    Article  CAS  PubMed  Google Scholar 

  22. Nasca C, Xenos D, Barone Y, Caruso A, Scaccianoce S, Matrisciano F et al (2013) l-acetylcarnitine causes rapid antidepressant effects through the epigenetic induction of mGlu2 receptors. Proc Natl Acad Sci U S A 110(12):4804–4809

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Rozas G, Guerra MJ, Labandeira-Garcia JL (1997) An automated rotarod method for quantitative drug-free evaluation of overall motor deficits in rat models of parkinsonism. Brain Res Brain Res Protoc 2:75–84

    Article  CAS  PubMed  Google Scholar 

  24. Espejo EF, Montoro RJ, Armengol JA, López-Barneo J (1998) Cellular and functional recovery of Parkinsonian rats after intrastriatal transplantation of carotid body cell aggregates. Neuron 20:197–206

    Article  CAS  PubMed  Google Scholar 

  25. Colado MI, O'Shea E, Granados R, Misra A, Murray TK, Green AR (1997) A study of the neurotoxic effect of MDMA (‘ecstasy’) on 5-HT neurones in the brains of mothers and neonates following administration of the drug during pregnancy. Br J Pharmacol 121:827–833

  26. Ellman GL (1959) Tissue sulfhydryl groups. Arch Biochem Biophys 82:70–77

    Article  CAS  PubMed  Google Scholar 

  27. Raghavendra V, Kulkarni SK (2000) Melatonin reversal of DOI-induced hypophagia in rats; possible mechanism by suppressing 5-HT(2A) receptor-mediated activation of HPA axis. Brain Res 860:112–118

    Article  CAS  PubMed  Google Scholar 

  28. van den Munckhof P, Luk KC, Ste-Marie L, Montgomery J, Blanchet PJ, Sadikot AF et al (2003) Pitx3 is required for motor activity and for survival of a subset of midbrain dopaminergic neurons. Development 130:2535–2542

    Article  PubMed  Google Scholar 

  29. Castelo-Branco G, Rawal N, Arenas E (2004) GSK-3beta inhibition/beta-catenin stabilization in ventral midbrain precursors increases differentiation into dopamine neurons. J Cell Sci 117:5731–5737

    Article  CAS  PubMed  Google Scholar 

  30. Kuruvilla KP, Nandhu MS, Paul J, Paulose CS (2013) Oxidative stress mediated neuronal damage in the corpus striatum of 6-hydroxydopamine lesioned Parkinson’s rats: neuroprotection by serotonin, GABA and bone marrow cells supplementation. J Neurol Sci 331:31–37

    Article  CAS  PubMed  Google Scholar 

  31. Rani PJ, Panneerselvam C (2002) Effect of L-carnitine on brain lipid peroxidation and antioxidant enzymes in old rats. J Gerontol A Biol Sci Med Sci 57:B134–B137

    Article  PubMed  Google Scholar 

  32. Hagen TM, Liu J, Lykkesfeldt J, Wehr CM, Ingersoll RT, Vinarsky V et al (2002) Feeding acetyl-L-carnitine and lipoic acid to old rats significantly improves metabolic function while decreasing oxidative stress. Proc Natl Acad Sci U S A 99:1870–1875

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Zhang H, Jia H, Liu J, Ao N, Yan B, Shen W et al (2010) Combined R-alpha-lipoic acid and acetyl-L-carnitine exerts efficient preventative effects in a cellular model of Parkinson’s disease. J Cell Mol Med 14:215–225

    Article  CAS  PubMed  Google Scholar 

  34. Truong L, Allbutt H, Kassiou M, Henderson JM (2006) Developing a preclinical model of Parkinson’s disease: a study of behaviour in rats with graded 6-OHDA lesions. Behav Brain Res 169:1–9

    Article  CAS  PubMed  Google Scholar 

  35. Jones GH, Robbins TW (1992) Differential effects of mesocortical, mesolimbic, and mesostriatal dopamine depletion on spontaneous, conditioned, and drug-induced locomotor activity. Pharmacol Biochem Behav 43:887–895

    Article  CAS  PubMed  Google Scholar 

  36. Hauber W (1998) Involvement of basal ganglia transmitter systems in movement initiation. Prog Neurobiol 56:507–540

    Article  CAS  PubMed  Google Scholar 

  37. Grealish S, Mattsson B, Draxler P, Björklund A (2010) Characterisation of behavioural and neurodegenerative changes induced by intranigral 6-hydroxydopamine lesions in a mouse model of Parkinson’s disease. Eur J Neurosci 31:2266–2278

    Article  PubMed  Google Scholar 

  38. Langston JW, Forno LS, Tetrud J, Reeves AG, Kaplan JA, Karluk D (1999) Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure. Ann Neurol 46:598–605

    Article  CAS  PubMed  Google Scholar 

  39. Marinova-Mutafchieva L, Sadeghian M, Broom L, Davis JB, Medhurst AD, Dexter DT (2009) Relationship between microglial activation and dopaminergic neuronal loss in the substantia nigra: a time course study in a 6-hydroxydopamine model of Parkinson’s disease. J Neurochem 110:966–975

    Article  CAS  PubMed  Google Scholar 

  40. Halliday GM, Stevens CH (2011) Glia: initiators and progressors of pathology in Parkinson’s disease. Mov Disord 26:6–17

    Article  PubMed  Google Scholar 

  41. Yang YJ, Zhang S, Ding JH, Zhou F, Hu G (2009) Iptakalim protects against MPP+-induced degeneration of dopaminergic neurons in association with astrocyte activation. Int J Neuropsychopharmacol 12:317–327

    Article  CAS  PubMed  Google Scholar 

  42. Chung YC, Kim SR, Park JY, Chung ES, Park KW, Won SY et al (2011) Fluoxetine prevents MPTP-induced loss of dopaminergic neurons by inhibiting microglial activation. Neuropharmacology 60:963–974

    Article  CAS  PubMed  Google Scholar 

  43. Altun Z, Olgun Y, Ercetin P, Aktas S, Kirkim G, Serbetcioglu B et al (2014) Protective effect of acetyl-l-carnitine against cisplatin ototoxicity: role of apoptosis-related genes and pro-inflammatory cytokines. Cell Prolif 47:72–80

    Article  CAS  PubMed  Google Scholar 

  44. Stott SR, Barker RA (2014) Time course of dopamine neuron loss and glial response in the 6-OHDA striatal mouse model of Parkinson’s disease. Eur J Neurosci 39:1042–1056

    Article  PubMed  Google Scholar 

  45. Andersson E, Tryggvason U, Deng Q, Friling S, Alekseenko Z, Robert B et al (2006) Identification of intrinsic determinants of midbrain dopamine neurons. Cell 124:393–405

    Article  CAS  PubMed  Google Scholar 

  46. Volpicelli F, De Gregorio R, Pulcrano S, Perrone-Capano C, di Porzio U, Bellenchi GC (2012) Direct regulation of Pitx3 expression by Nurr1 in culture and in developing mouse midbrain. PLoS ONE 7:e30661

  47. Das S, Dutta K, Kumawat KL, Ghoshal A, Adhya D, Basu A (2011) Abrogated inflammatory response promotes neurogenesis in a murine model of Japanese encephalitis. PLoS ONE 6:e17225

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Baker SA, Baker KA, Hagg T (2004) Dopaminergic nigrostriatal projections regulate neural precursor proliferation in the adult mouse subventricular zone. Eur J Neurosci 20:575–579

    Article  PubMed  Google Scholar 

  49. Park D, Xiang AP, Mao FF, Zhang L, Di CG, Liu XM et al (2010) Nestin is required for the proper self-renewal of neural stem cells. Stem Cells 28:2162–2171

    Article  CAS  PubMed  Google Scholar 

  50. Roybon L, Hjalt T, Stott S, Guillemot F, Li JY, Brundin P (2009) Neurogenin2 directs granule neuroblast production and amplification while NeuroD1 specifies neuronal fate during hippocampal neurogenesis. PLoS ONE 4:e4779

    Article  PubMed  PubMed Central  Google Scholar 

  51. Gao Z, Ure K, Ables JL, Lagace DC, Nave KA, Goebbels S et al (2009) Neurod1 is essential for the survival and maturation of adult-born neurons. Nat Neurosci 12:1090–1092

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  52. Cuccurazzu B, Bortolotto V, Valente MM, Ubezio F, Koverech A, Canonico PL et al (2013) Upregulation of mGlu2 receptors via NF-kappaB p65 acetylation is involved in the proneurogenic and antidepressant effects of acetyl-L-carnitine. Neuropsychopharmacology 38:2220–2230

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  53. Chen G, Bower KA, Ma C, Fang S, Thiele CJ, Luo J (2004) Glycogen synthase kinase 3beta (GSK3beta) mediates 6-hydroxydopamine-induced neuronal death. Faseb J 18:1162–1164

    Article  CAS  PubMed  Google Scholar 

  54. Jiang X, Tian Q, Wang Y, Zhou XW, Xie JZ, Wang JZ et al (2011) Acetyl-L-carnitine ameliorates spatial memory deficits induced by inhibition of phosphoinositol-3 kinase and protein kinase C. J Neurochem 118:864–878

    Article  CAS  PubMed  Google Scholar 

  55. Kalani MY, Cheshier SH, Cord BJ, Bababeygy SR, Vogel H, Weissman IL et al (2008) Wnt-mediated self-renewal of neural stem/progenitor cells. Proc Natl Acad Sci U S A 105:16970–16975

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  56. Kunke D, Bryja V, Mygland L, Arenas E, Krauss S (2009) Inhibition of canonical Wnt signaling promotes gliogenesis in P0-NSCs. Biochem Biophys Res Commun 386:628–633

    Article  CAS  PubMed  Google Scholar 

  57. Galli S, Lopes DM, Ammari R, Kopra J, Millar SE, Gibb A et al (2014) Deficient Wnt signalling triggers striatal synaptic degeneration and impaired motor behaviour in adult mice. Nat Commun 5:4992

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgments

The authors are grateful to the Director, CDRI, Lucknow, India, for constant encouragement and support during the study. This work is supported by CSIR Network Grant miND (BSC0115) to Shubha Shukla. Authors also acknowledge the Indian Council of Medical Research (ICMR) and Council of Scientific and Industrial Research (CSIR) for providing research fellowship to Sonu Singh and Akanksha Mishra, respectively. The CSIR-CDRI communication number of this article is 9032.

Author information

Authors and Affiliations

  1. Pharmacology Division, CSIR-Central Drug Research Institute (CSIR-CDRI), BS-10/1, Sector 10, Jankipuram extension, Sitapur Road, Lucknow, 226031, India

    Sonu Singh, Akanksha Mishra & Shubha Shukla

Authors
  1. Sonu Singh
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Akanksha Mishra
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shubha Shukla
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Shubha Shukla.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Singh, S., Mishra, A. & Shukla, S. ALCAR Exerts Neuroprotective and Pro-Neurogenic Effects by Inhibition of Glial Activation and Oxidative Stress via Activation of the Wnt/β-Catenin Signaling in Parkinsonian Rats. Mol Neurobiol 53, 4286–4301 (2016). https://doi.org/10.1007/s12035-015-9361-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12035-015-9361-5

Keywords

Search

Navigation